SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-010233
Filing Date
2022-03-15
Accepted
2022-03-15 08:30:30
Documents
7
Period of Report
2022-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A evok-def14a_20220427.htm DEF 14A 1085189
2 GRAPHIC g5noy5k5nioc000004.jpg GRAPHIC 4256
3 GRAPHIC g5noy5k5nioc000003.jpg GRAPHIC 17621
4 GRAPHIC g5noy5k5nioc000001.jpg GRAPHIC 17621
5 GRAPHIC g5noy5k5nioc000006.jpg GRAPHIC 341457
6 GRAPHIC g5noy5k5nioc000005.jpg GRAPHIC 651850
7 GRAPHIC g5noy5k5nioc000002.jpg GRAPHIC 4256
  Complete submission text file 0001564590-22-010233.txt   2515239
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 22739221
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences